Detalhe da pesquisa
1.
An open label study of the safety and efficacy of a single dose of weekly chloroquine and azithromycin administered for malaria prophylaxis in healthy adults challenged with 7G8 chloroquine-resistant Plasmodium falciparum in a controlled human malaria infection model.
Malar J
; 19(1): 336, 2020 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32938444
2.
Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population.
J Infect Dis
; 220(11): 1761-1770, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31549155
3.
Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic Antigens.
Infect Immun
; 87(3)2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559218
4.
Corrigendum to: Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population.
J Infect Dis
; 221(7): 1204, 2020 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31773155
5.
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01.
Malar J
; 12: 29, 2013 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23342996
6.
Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
Clin Infect Dis
; 54(2): 232-9, 2012 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22052893
7.
Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria.
N Engl J Med
; 369(14): 1381-2, 2013 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24088113
8.
Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.
JCI Insight
; 2(1): e89154, 2017 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28097230
9.
Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy.
PLoS Negl Trop Dis
; 10(2): e0004423, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26919472
10.
Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults.
PLoS One
; 10(7): e0131571, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26148007
11.
DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.
PLoS One
; 8(2): e55571, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23457473
12.
Plasmodium falciparum infection during suppressive prophylaxis with mefloquine does not induce an antibody response to merozoite surface protein-1(42).
Am J Trop Med Hyg
; 84(5): 825-9, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21540397